Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis

Authors
Sang Hoon LeeYoomi YeoTae-Hyung KimHong Lyeol LeeJin Hwa LeeYong Bum ParkJong Sun ParkYee Hyung KimJin Woo SongByung Woo JhunHyun Jung KimJinkyeong ParkSoo-Taek UhYoung Whan KimDong Soon KimMoo Suk Park
Department
Dept. of Internal Medicine (내과학)
Issue Date
2019
Citation
Tuberculosis and Respiratory Diseases, Vol.82(2) : 102-117, 2019
ISSN
2005-6184
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome. The members of the Korean Academy of Tuberculosis and Respiratory Diseases as well as the participating members of the Korea Interstitial Lung Disease Study Group drafted this clinical practice guideline for IPF management. This guideline includes a wide range of topics, including the epidemiology, pathogenesis, risk factors, clinical features, diagnosis, treatment, prognosis, and acute exacerbation of IPF in Korea. Additionally, we suggested the PICO for the use of pirfenidone and nintendanib and for lung transplantation for the treatment of patients with IPF through a systemic literature review using experts’ help in conducting a meta-analysis. We recommend this guideline to physicians, other health care professionals, and government personnel in Korea, to facilitate the treatment of patients with IPF.
Keywords
Idiopathic Pulmonary FibrosisDiagnosisDisease ManagementKorea
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/41949
Appears in Collections:
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
Keimyung Author(s)
김현정
Full Text
https://www.e-trd.org/DOIx.php?id=10.4046/trd.2018.0091
File in this Item
oak-2019-0076.pdf(3.67 MB)Download
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE